Plotnick R D
Graduate School of Public Affairs, University of Washington, Seattle 98195.
Int J Addict. 1994 Feb;29(3):339-59. doi: 10.3109/10826089409047385.
Benefits and costs are discussed when substance use prevention programs are proposed and evaluated, but systematic benefit-cost analysis has rarely been applied to such programs. This article argues that benefit-cost analysis can and should be used to structure evaluations of substance use prevention programs, and, in general, any program aimed at preventing dysfunctional behavior. It presents the basic ideas of benefit-cost analysis and its closely related tool, cost-effectiveness analysis. It then sketches a "blueprint" for a benefit-cost analysis of an experimental drug use prevention program intended to prevent relapse into drug use by parents receiving methadone maintenance and to lower the risk that the children of these parents will become substance users. The blueprint can help structure evaluations of other prevention programs.
在提出和评估药物使用预防项目时会讨论其收益和成本,但系统的收益成本分析很少应用于此类项目。本文认为,收益成本分析能够且应该用于构建药物使用预防项目的评估,一般而言,也适用于任何旨在预防功能失调行为的项目。文章介绍了收益成本分析及其密切相关工具成本效益分析的基本理念。然后概述了一个针对一项实验性药物使用预防项目进行收益成本分析的“蓝图”,该项目旨在防止接受美沙酮维持治疗的父母复吸毒品,并降低这些父母的子女成为药物使用者的风险。该蓝图有助于构建对其他预防项目的评估。